Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-Rich Plasma Gel plus Glucantime vs Glucantime Alone for Ulcerated Cutaneous Leishmaniasis
TCTR20251125007Phase 4Completed
- Sponsor
- Self-Funded Health
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by Self-Funded Health. Started Dec 2023; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on TCTR20251125007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251125007.